<DOC>
	<DOCNO>NCT00968786</DOCNO>
	<brief_summary>The home monitoring automate measure device may improve management chronic disease , may decrease incidence fatal disease . The investigator conduct small sample short observation time research explore feasibility carry later large-scale research .</brief_summary>
	<brief_title>Home Monitoring Management Hypertension Diabetes Mellitus</brief_title>
	<detailed_description>Background : Approximately 40 % type 2 diabetes patient also hypertension . There many risk factor patient , 's difficult manage patient . With improvement accuracy automate measure device , patient use device monitor blood pressure , blood glucose , body weight , visceral fat indicator home , contribute participation management disease . The home monitoring may improve management chronic disease , may decrease incidence fatal disease stroke , myocardial infarction , heart failure , renal dysfunction serious disease . Large-scale research carry prove whether home monitoring valuable prevent incidence fatal disease stroke , myocardial infarction , heart failure , renal dysfunction . And first , necessary conduct small sample ( n = 100 ) , short observation time ( six month ) research , monitor blood pressure , blood glucose , body weight indicator intermediate target detection , explore feasibility carry large-scale research . Objective : In hypertensive type 2 diabetes patient , conduct open randomize control trial explore patient 's use blood pressure monitor , blood glucose meter pedometer home , use body composition measurement instrument clinic , effective control blood pressure , blood glucose , body weight , reduce risk patient albuminuria . Inclusion criterion : 1 . Regardless whether currently receive antihypertensive therapy , systolic blood pressure high 140 mmHg diastolic blood pressure high than90 mmHg . 2 . Whether use oral hypoglycemic agent insulin injection , fast plasma high 7.0 mmol/L , postprandial blood glucose high 11.1 mmol/L . Exclusion criterion : 1. life-threatening disease . 2 . With various effect metabolic disease hyperthyroidism , hypothyroidism , etc . 3. stroke , myocardial infarction serious cardiovascular cerebrovascular disease occur within 3 month . 4. serum creatinine level hugher 176.8 mol/L . 5 . Dementia severe cognitive decline . 6. unable long-term follow-up study agree participate trial . Sample estimate statistical analysis : In accordance 6-month follow-up , average difference two group , systolic blood pressure 3 mmHg , glycated hemoglobin 0.2 % , condition a= 0.05 b= 0.10 , research need group 50 patient , total 100 . Major finding statistic use test compare two group 6 month follow-up observation baseline change margin , calculate 95 % confidence interval . At time also use non-parametric Wilcoxon test compare blood pressure , blood glucose many follow-up result repeat measurement .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Regardless whether currently receive antihypertensive therapy , systolic blood pressure high 140 mmHg diastolic blood pressure high 90 mmHg . Whether use oral hypoglycemic agent insulin injection , fast plasma high 7.0 mmol/L , postprandial blood glucose high 11.1 mmol/L . With lifethreatening disease . With various effect metabolic disease hyperthyroidism , hypothyroidism , etc . Stroke , myocardial infarction serious cardiovascular cerebrovascular disease occur within 3 month . Serum creatinine level high 176.8 mmol/L Dementia severe cognitive decline Unable longterm followup agree participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>hypertension</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>home monitoring</keyword>
</DOC>